Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$3.74 - $5.45 $234,434 - $341,622
-62,683 Reduced 33.07%
126,886 $474,000
Q2 2023

Aug 14, 2023

BUY
$3.79 - $8.3 $116,273 - $254,635
30,679 Added 19.31%
189,569 $809,000
Q1 2023

May 15, 2023

BUY
$5.89 - $10.52 $277,583 - $495,786
47,128 Added 42.17%
158,890 $1.09 Million
Q4 2022

Feb 14, 2023

BUY
$5.69 - $10.07 $280,539 - $496,491
49,304 Added 78.94%
111,762 $885,000
Q3 2022

Nov 14, 2022

SELL
$7.17 - $13.87 $24,306 - $47,019
-3,390 Reduced 5.15%
62,458 $600,000
Q2 2022

Aug 15, 2022

SELL
$5.86 - $13.23 $78,242 - $176,646
-13,352 Reduced 16.86%
65,848 $477,000
Q1 2021

May 17, 2021

SELL
$14.42 - $21.39 $59,122 - $87,699
-4,100 Reduced 4.92%
79,200 $1.16 Million
Q4 2020

Feb 03, 2021

SELL
$16.56 - $18.94 $172,224 - $196,976
-10,400 Reduced 11.1%
83,300 $1.45 Million
Q3 2020

Nov 16, 2020

SELL
$17.41 - $19.89 $41,784 - $47,736
-2,400 Reduced 2.5%
93,700 $1.72 Million
Q2 2020

Aug 12, 2020

SELL
$14.43 - $19.16 $95,238 - $126,456
-6,600 Reduced 6.43%
96,100 $1.72 Million
Q1 2020

May 06, 2020

BUY
$11.67 - $22.53 $115,533 - $223,047
9,900 Added 10.67%
102,700 $1.67 Million
Q3 2019

Nov 12, 2019

BUY
$16.3 - $23.37 $353,710 - $507,129
21,700 Added 30.52%
92,800 $1.88 Million
Q2 2019

Aug 14, 2019

BUY
$13.1 - $22.1 $20,960 - $35,360
1,600 Added 2.3%
71,100 $1.57 Million
Q1 2019

May 13, 2019

BUY
$8.38 - $15.5 $133,242 - $246,450
15,900 Added 29.66%
69,500 $948,000
Q4 2018

Feb 11, 2019

BUY
$8.65 - $16.28 $51,035 - $96,052
5,900 Added 12.37%
53,600 $485,000
Q3 2018

Nov 14, 2018

SELL
$14.45 - $20.25 $426,130 - $597,172
-29,490 Reduced 38.2%
47,700 $787,000
Q2 2018

Aug 03, 2018

SELL
$10.25 - $17.45 $2.97 Million - $5.06 Million
-289,813 Reduced 78.97%
77,190 $1.08 Million
Q1 2018

May 07, 2018

SELL
$9.1 - $13.7 $5.02 Million - $7.56 Million
-551,997 Reduced 60.06%
367,003 $4.06 Million
Q4 2017

Feb 08, 2018

BUY
$8.35 - $14.4 $3.18 Million - $5.49 Million
381,000 Added 70.82%
919,000 $8.09 Million
Q3 2017

Nov 01, 2017

BUY
$11.1 - $14.5 $5.97 Million - $7.8 Million
538,000
538,000 $7.18 Million

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $122M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.